Cataracts among elderly prostate cancer patients receiving androgen deprivation therapy (ADT) in the United States

被引：0

作者：

Beebe-Dimmer, J.

Schwartz, K. A.

Cetin, K.

Morgenstern, H.

Yee, C.

Bartoces, M.

Shahinian, V. B.

Fryzek, J.

Acguavella, J. F.

机构：

[1] Wayne State Univ, Dept Internal Med, Karmanos Canc Inst, Detroit, MI 48202 USA

[2] Wayne State Univ, Dept Family Med, Karmanos Canc Inst, Detroit, MI USA

[3] Amgen Inc, Dept Global Epidemiol, Thousand Oaks, CA USA

[4] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA

[5] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA

[6] Karmanos Canc Inst, Detroit, MI USA

[7] Wayne State Univ, Dept Family Med, Detroit, MI USA

[8] Univ Michigan, Sch Med, Ann Arbor, MI USA

[9] Medimmune Inc, Gaithersburg, MD 20878 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.e15068

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e15068

引用

页数：1

共 50 条

[31] Androgen deprivation therapy (ADT) and testosterone (T) in prostate cancer patients: The lower is really the better
Perachino, M.
Cavalli, V.
Ferraris, V.
EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 204 - 204
[32] Influence of age on incident diabetes (DM) and cardiovascular disease (CVD) among prostate cancer survivors receiving androgen deprivation therapy (ADT)
Morgans, Alicia Katherine
Fan, Kang-Hsien
Koyama, Tatsuki
Albertsen, Peter C.
Goodman, Michael
Hamilton, Ann S.
Hoffman, Richard M.
Stanford, Janet L.
Stroup, Antoinette M.
Resnick, Matthew
Barocas, Daniel Ari
Derleth, Christina Louise
Penson, David F.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[33] Health-related quality of life of prostate cancer patients on androgen deprivation therapy (ADT)
Ko, C. H.
Lim, J.
Ng, C. F.
Wei, Y.
Ong, T. A.
Chu, P. S. K.
Chan, W.
Huang, C. Y.
Feng, K. K.
Teoh, J.
Ning, X.
Chiu, P.
Yee, C. H.
Leung, S.
BJU INTERNATIONAL, 2022, 129 : 6 - 6
[34] Healthcare resource use (HRU) in men with metastatic castration sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT) only or no treatment in the United States (US).
Ke, Xuehua
Lafeuille, Marie-Helene
Romdhani, Hela
Kinkead, Frederic
Francis, Peter St John
D'Andrea, Denise
Ryan, Charles J.
Freedland, Stephen J.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[35] Evaluation of persistence and adherence for oral and injectable androgen deprivation therapies (ADT) in United States (US) patients with prostate cancer (PC).
Hafron, Jason
Hong, Agnes
DePaauw-Holt, Simon
Romdhani, Hela
Kinkead, Frederic
Flanders, Scott C.
Ryan, Michael J.
Mckay, Rana R.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[36] Androgen deprivation therapy (ADT) and physical function in men with nonmetastatic prostate cancer
Breunis, H.
Leach, M.
Naglie, G.
Tannock, I. F.
Fleshner, N. E.
Krahn, M.
Duff-Canning, S.
Tomlinson, G.
Warde, P.
Alibhai, S. M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[37] Predictors of Clinical Metastasis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Abouassaly, Robert
Paciorek, Alan
Ryan, Charles J.
Carroll, Peter R.
Klein, Eric A.
CANCER, 2009, 115 (19) : 4470 - 4476
[38] Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Wu, Fang-Jen
Sheu, Shiow-Yunn
Lin, Herng-Ching
Chung, Shiu-Dong
UROLOGY, 2016, 95 : 145 - 149
[39] Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer
Tsai, Huei-Ting
Keating, Nancy L.
Van den Eeden, Stephen K.
Haque, Reina
Cassidy-Bushrow, Andrea E.
Yood, Marianne Ulcickas
Smith, Matthew R.
Potosky, Arnold L.
JOURNAL OF UROLOGY, 2015, 193 (06): : 1956 - 1962
[40] CHANGE IN ERECTILE FUNCTION DURING ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
Kanemitsu, Noriyuki
Soh, Jintetsu
Naitoh, Yasuyuki
Ochiai, Atsushi
Naya, Yoshio
Kamoi, Kazumi
Kawauchi, Akihiro
Miki, Tsuneharu
JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 246 - 246

← 1 2 3 4 5 →